Study of Alferon® LDO (Low Dose Oral) in Normal Volunteers

Clinical trial NCT00215826 · COMPLETED

Trial details

NCT number: NCT00215826
Sponsor: AIM ImmunoTech Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Severe Acute Respiratory Syndrome

Start date: 2004-11-01
Primary completion: 2006-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.